Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.4M
+53.7% from 2023
Prescriptions
8,548
$165.15 per claim
Patients
7,674
3,289 prescribers
Total spending, 2024
$1.4M
$183.95 per patient
Medicare prescription drug plans paid $1.4M for Menveo A-C-Y-W-135-Dip in 2024, for 8,548 prescriptions and refills to 7,674 patients (up 53.7% from 2023). The average cost per claim was $165.15.
California had the highest Medicare cost for Menveo A-C-Y-W-135-Dip in 2024: $437K for 2,811 claims, followed by Wisconsin ($87K).
Armaghan Azad, emergency medicine in Moreno Valley, CA, had the highest Medicare cost for Menveo A-C-Y-W-135-Dip in 2024: 501 claims costing $81K.
Menveo A-C-Y-W-135-Dip is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Armaghan Azad Moreno Valley, CA | Emergency Medicine | 501 | 494 | $81K |
| Pak H Lai Canby, OR | Pharmacist | 164 | 138 | $27K |
| Annette V Wagner |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,606 | 4,350 | 3,585 | $673K |
| 2023 | 2,380 | 5,356 | 4,758 | $918K |
| 2024 | 3,289 | 8,548 | 7,674 | $1.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Obstetrics & Gynecology |
| 110 |
| 92 |
| $18K |
| Lloyd P Vanwinkle Castroville, TX | Family Practice | 89 | 87 | $16K |
| Winnie L Mann Redmond, WA | Specialist | 59 | 47 | $9,981 |
| Cedric E Davis II Parker, AZ | Family Practice | 54 | 49 | $8,528 |
| Nichole Hansen-Cruz San Diego, CA | Family Practice | 53 | 53 | $8,003 |
| Mark P Selitsky Detroit, MI | Internal Medicine | 40 | 40 | $7,247 |
| Clifford Quan Antioch, CA | Infectious Disease | 47 | 47 | $7,097 |
| Amanda I Mullins Santa Monica, CA | Family Practice | 47 | 47 | $7,097 |
| Eldridge G Burns Jr. Seward, NE | Family Practice | 44 | 41 | $7,075 |
| Jill K Gersh Lone Tree, CO | Internal Medicine | 45 | 45 | $6,795 |
| Rushdi Alul Chicago, IL | Emergency Medicine | 42 | 41 | $6,607 |
| Leyla O Shune Westwood, KS | Hematology-Oncology | 38 | 30 | $6,469 |
| Anthony J Oliva Jr. San Antonio, TX | Internal Medicine | 35 | 35 | $5,869 |
| Federico Hinestrosa Orlando, FL | Infectious Disease | 33 | 31 | $5,621 |
| Vidush P Athyal Rochester, NY | Family Practice | 36 | 36 | $5,436 |
| Laura A Rush Los Angeles, CA | Family Practice | 36 | 36 | $5,436 |
| Daniel G Wallace La Mesa, CA | Internal Medicine | 35 | 34 | $5,285 |
| John R Bogdasarian Fitchburg, MA | Otolaryngology | 31 | 30 | $5,248 |
| Michael C Maine Jr. San Diego, CA | Family Practice | 34 | 34 | $5,134 |
| Jason A Torrente Hamilton, NJ | Family Practice | 30 | 29 | $4,949 |
| Kathleen K Christians Milwaukee, WI | General Surgery | 25 | 20 | $4,898 |
| Nausheen Ahmed Westwood, KS | Hematology-Oncology | 30 | 22 | $4,801 |
| Joseph P McGuirk Kansas City, KS | Hematology-Oncology | 32 | 26 | $4,659 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 8,552 | $1.4M |